US FDA invites feedback on IOM advice to scrap 510(k) process
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration is inviting feedback from the public on a controversial report by the Institute of Medicine that calls on the agency to abandon its pre-market notification process for clearing most medium- and low-risk medical devices in favour of an entirely new framework.